Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results

MeSH terms

• Adult
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / pharmacology
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Combined Modality Therapy
• Deoxycytidine / administration & dosage
• Deoxycytidine / analogs & derivatives
• Female
• Gemcitabine
• Hodgkin Disease / drug therapy
• Hodgkin Disease / surgery*
• Humans
• Kaplan-Meier Estimate
• Male
• Melphalan / administration & dosage
• Middle Aged
• Recurrence
• Remission Induction
• Salvage Therapy*
• Stem Cell Transplantation*
• Transplantation Conditioning / methods*
• Transplantation, Homologous
• Treatment Outcome
• Vidarabine / administration & dosage
• Vidarabine / analogs & derivatives
• Young Adult